Yuki Narita

475 total citations
33 papers, 340 citations indexed

About

Yuki Narita is a scholar working on Nephrology, Physiology and Surgery. According to data from OpenAlex, Yuki Narita has authored 33 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 6 papers in Physiology and 5 papers in Surgery. Recurrent topics in Yuki Narita's work include Dialysis and Renal Disease Management (8 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Chemotherapy-induced organ toxicity mitigation (3 papers). Yuki Narita is often cited by papers focused on Dialysis and Renal Disease Management (8 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Chemotherapy-induced organ toxicity mitigation (3 papers). Yuki Narita collaborates with scholars based in Japan, Australia and United States. Yuki Narita's co-authors include Sumío Hirata, Daisuke Kadowaki, Masaki Fukunaga, Hideyuki Saito, Hirofumi Jono, Atsushi Nakajima, Takayo Murase, Gaku TANAKA, Kenichiro Kitamura and Masaki Otagiri and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Life Sciences.

In The Last Decade

Yuki Narita

31 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Narita Japan 11 111 96 51 46 32 33 340
Li‐Hsuan Wang Taiwan 15 37 0.3× 141 1.5× 68 1.3× 31 0.7× 46 1.4× 42 532
Fumihiko Hinoshita Japan 12 75 0.7× 70 0.7× 60 1.2× 34 0.7× 18 0.6× 52 424
Seyed H. Farzaneh United States 9 108 1.0× 249 2.6× 89 1.7× 125 2.7× 23 0.7× 12 466
Cassandra Johnson United States 7 119 1.1× 254 2.6× 41 0.8× 180 3.9× 17 0.5× 13 499
Emilie Kalbacher France 11 116 1.0× 80 0.8× 63 1.2× 105 2.3× 17 0.5× 20 445
Nicholas C. Tonial Canada 5 126 1.1× 100 1.0× 17 0.3× 46 1.0× 12 0.4× 7 290
Sura Al Zoubi Jordan 6 23 0.2× 121 1.3× 77 1.5× 45 1.0× 13 0.4× 14 415
Meihong Wang China 4 69 0.6× 195 2.0× 28 0.5× 77 1.7× 7 0.2× 7 311
Caroline Pelletier France 9 221 2.0× 231 2.4× 74 1.5× 224 4.9× 21 0.7× 15 655
Shivani Jaswal India 8 43 0.4× 89 0.9× 29 0.6× 35 0.8× 31 1.0× 32 361

Countries citing papers authored by Yuki Narita

Since Specialization
Citations

This map shows the geographic impact of Yuki Narita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Narita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Narita more than expected).

Fields of papers citing papers by Yuki Narita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Narita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Narita. The network helps show where Yuki Narita may publish in the future.

Co-authorship network of co-authors of Yuki Narita

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Narita. A scholar is included among the top collaborators of Yuki Narita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Narita. Yuki Narita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kondo, Yuki, Akira Yoshida, Hiroyuki Nishimura, et al.. (2024). Evaluation of a creatinine clearance correction equation based on body fat mass in older Japanese patients with diabetes. Frontiers in Medicine. 11. 1228383–1228383. 1 indexed citations
2.
Narita, Yuki, Hirofumi Jono, Yutaka Kakizoe, et al.. (2023). Suppression of Indoxyl Sulfate Accumulation Reduces Renal Fibrosis in Sulfotransferase 1a1-Deficient Mice. International Journal of Molecular Sciences. 24(14). 11329–11329. 9 indexed citations
3.
Kakizoe, Yutaka, Miyuki Nakagawa, Yuki Narita, et al.. (2023). A Serine Protease Inhibitor, Camostat Mesilate, Suppresses Urinary Plasmin Activity and Alleviates Hypertension and Podocyte Injury in Dahl Salt-Sensitive Rats. International Journal of Molecular Sciences. 24(21). 15743–15743. 1 indexed citations
4.
Kakizoe, Yutaka, Masataka Adachi, Yuki Narita, et al.. (2022). Camostat mesilate, a serine protease inhibitor, exerts aquaretic effects and decreases urinary exosomal AQP2 levels. Journal of Pharmacological Sciences. 150(4). 204–210.
5.
Kakizoe, Yutaka, Masataka Adachi, Yuki Narita, et al.. (2022). The serine protease plasmin plays detrimental roles in epithelial sodium channel activation and podocyte injury in Dahl salt-sensitive rats. Hypertension Research. 46(1). 50–62. 8 indexed citations
6.
Narita, Yuki, et al.. (2021). Suppressed Hepatic Production of Indoxyl Sulfate Attenuates Cisplatin-Induced Acute Kidney Injury in Sulfotransferase 1a1-Deficient Mice. International Journal of Molecular Sciences. 22(4). 1764–1764. 12 indexed citations
7.
Narita, Yuki, et al.. (2021). Improved Formula for Predicting Hemodialyzability of Intravenous and Oral Drugs. Blood Purification. 50(6). 865–875. 2 indexed citations
8.
Oda, Kazutaka, et al.. (2021). Clinical evaluation of an authorized medical equipment based on high performance liquid chromatography for measurement of serum voriconazole concentration. Journal of Pharmaceutical Health Care and Sciences. 7(1). 42–42. 4 indexed citations
9.
Narita, Yuki, Köichi Fukumoto, Masaki Fukunaga, et al.. (2020). Comparative Study of Constipation Exacerbation by Potassium Binders Using a Loperamide-Induced Constipation Model. International Journal of Molecular Sciences. 21(7). 2491–2491. 10 indexed citations
10.
Fukunaga, Masaki, Daisuke Kadowaki, Mika Mori, et al.. (2020). In vivo evaluation of drug dialyzability in a rat model of hemodialysis. PLoS ONE. 15(6). e0233925–e0233925. 4 indexed citations
11.
12.
Fukunaga, Masaki, Atsushi Nakajima, Gaku TANAKA, et al.. (2019). Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats. Clinical and Experimental Nephrology. 23(7). 908–919. 65 indexed citations
13.
Narita, Yuki, Yutaka Kakizoe, Yuki Kondo, et al.. (2019). Edoxaban Exerts Antioxidant Effects Through FXa Inhibition and Direct Radical-Scavenging Activity. International Journal of Molecular Sciences. 20(17). 4140–4140. 11 indexed citations
14.
Kondo, Yuki, Yoichi Ishitsuka, Yuki Narita, et al.. (2019). Knowledge and awareness of nonpharmacist salespersons regarding over-the-counter drug use in patients with chronic kidney disease in Japan. PLoS ONE. 14(3). e0213763–e0213763. 1 indexed citations
15.
Oda, Kazutaka, et al.. (2019). Development and evaluation of a vancomycin dosing nomogram to achieve the target area under the concentration-time curve. A retrospective study. Journal of Infection and Chemotherapy. 26(5). 444–450. 17 indexed citations
16.
Kadowaki, Daisuke, Shigeyuki Miyamura, Kenichiro Kitamura, et al.. (2018). Benzbromarone Attenuates Oxidative Stress in Angiotensin II‐ and Salt‐Induced Hypertensive Model Rats. Oxidative Medicine and Cellular Longevity. 2018(1). 7635274–7635274. 21 indexed citations
17.
Sugawara, Yasuhiko, Yuki Narita, Daiki Yoshii, et al.. (2018). Duodenal Ulcer as a Postoperative Complication in the Donor in Living-Donor Liver Transplantation. Transplantation Proceedings. 50(4). 1129–1131. 3 indexed citations
18.
Narita, Yuki, Miki Ueda, Kohei Uchimura, et al.. (2016). Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model. Journal of Pharmacological Sciences. 130(2). 110–116. 12 indexed citations
19.
Ueda, Miki, Kohei Uchimura, Yuki Narita, et al.. (2015). The Serine Protease Inhibitor Camostat Mesilate Attenuates the Progression of Chronic Kidney Disease through its Antioxidant Effects. ˜The œNephron journals/Nephron journals. 129(3). 223–232. 13 indexed citations
20.
Hachiya, Yudo, Yuki Narita, Hirokazu Iwata, et al.. (1999). Status of bone banks in Japan. Transplantation Proceedings. 31(5). 2032–2035. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li‐Hsuan Wang Breakdown of academic impact, for papers by Fumihiko Hinoshita Breakdown of academic impact, for papers by Seyed H. Farzaneh Breakdown of academic impact, for papers by Cassandra Johnson Breakdown of academic impact, for papers by Emilie Kalbacher Breakdown of academic impact, for papers by Nicholas C. Tonial Breakdown of academic impact, for papers by Sura Al Zoubi Breakdown of academic impact, for papers by Meihong Wang Breakdown of academic impact, for papers by Caroline Pelletier Breakdown of academic impact, for papers by Shivani Jaswal
Rankless by CCL
2026